P854: HEXABODY-CD38 INDUCES TROGOCYTOSIS AND EFFECTIVELY INDUCES COMPLEMENT-MEDIATED TUMOR CELL LYSIS AFTER TREATMENT WITH DARATUMUMAB OR ISATUXIMAB IN VITRO

• I. H. Hiemstra,
• K. Santegoets,
• M. L. Janmaat,
• W. Ten Hagen,
• S. Van Dooremalen,
• B. E. De Goeij,
• S. Bosgra,
• A. K. Sasser,
• E. C. Breij

Affiliations

I. H. Hiemstra

1 Genmab BV, Utrecht, Netherlands

K. Santegoets

1 Genmab BV, Utrecht, Netherlands

M. L. Janmaat

1 Genmab BV, Utrecht, Netherlands

W. Ten Hagen

1 Genmab BV, Utrecht, Netherlands

S. Van Dooremalen

1 Genmab BV, Utrecht, Netherlands

B. E. De Goeij

1 Genmab BV, Utrecht, Netherlands

S. Bosgra

1 Genmab BV, Utrecht, Netherlands

A. K. Sasser

2 Genmab US, Inc, Plainsboro, NJ, United States of America

E. C. Breij

1 Genmab BV, Utrecht, Netherlands